Facebook
Twitter
Telegram
Report an ErrorNektar Therapeutics Financial Ratios 2011-2024 | NKTR
Annual Financial Ratios Nektar Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.6 | -0.7 | -3.9 | -7.9 | -8.1 | 10.7 | -133.0 | -10.7 | -22.3 | -34.5 | -10.0 | -5.7 | -5.4 |
P/S |
1.9 | 2.8 | 20.0 | 23.0 | 31.0 | 6.1 | 41.8 | 9.9 | 7.8 | 9.3 | 10.9 | 12.0 | 10.1 |
EPS |
-1.4 | -2.0 | -2.9 | -2.5 | -2.5 | 4.0 | -0.6 | -1.1 | -0.6 | -0.4 | -1.4 | -1.5 | -1.2 |
EV (Enterprise Value) |
399 M | 516 M | 2.45 B | 3.78 B | 4.03 B | 7.55 B | 13.3 B | 2.06 B | 2.25 B | 2.25 B | 2.1 B | 1.4 B | 1.11 B |
EBITDA per Share |
-1.35 | -1.94 | -2.36 | -2.31 | -2.44 | 4.12 | -0.185 | -0.698 | -0.125 | -0.028 | -0.915 | -1.09 | -0.965 |
EV/EBITDA |
-5.6 | -9.8 | -8.7 | 10.5 | -452.9 | -18.7 | -120.7 | -553.7 | -16.1 | -8.6 | -8.4 | ||
PEG |
0.01 | 0.0 | 0.01 | 0.02 | 0.05 | 0.01 | -3.05 | 0.13 | 0.49 | -0.49 | -1.5 | 0.22 | 0.03 |
P/B |
1.3 | 0.7 | 3.0 | 3.3 | 2.5 | 4.3 | 146.4 | 18.6 | 281.0 | 51.1 | -18.0 | 20.8 | 3.6 |
P/CF |
-0.9 | -0.9 | -4.9 | -11.2 | -10.0 | 10.4 | -142.7 | -13.3 | -21.4 | -12.2 | -38.0 | -7.0 | -5.8 |
ROE % |
-210.75 | -100.43 | -77.09 | -41.26 | -31.36 | 39.67 | -110.09 | -174.21 | -1262.67 | -148.40 | 180.21 | -365.51 | -67.73 |
ROA % |
-69.36 | -51.82 | -46.89 | -28.88 | -22.29 | 31.69 | -19.00 | -26.99 | -16.17 | -12.21 | -37.28 | -34.52 | -22.09 |
ROCE % |
-201.31 | -102.60 | -65.65 | -39.46 | -27.10 | 33.26 | -9.64 | -22.72 | -6.66 | -4.37 | -35.72 | -33.28 | -37.44 |
Current Ratio |
1.5 | 2.1 | 2.6 | 3.3 | 4.0 | 17.5 | 5.8 | 5.9 | 5.7 | 4.5 | 2.6 | 4.0 | 1.0 |
DSO |
14.6 | 56.4 | 109.9 | 90.3 | 117.2 | 13.2 | 5.9 | 34.6 | 31.5 | 6.6 | 5.5 | 26.1 | 25.2 |
DIO |
190.8 | 295.3 | 227.9 | 262.0 | 216.3 | 170.2 | 128.2 | 134.2 | 121.4 | 165.7 | 127.5 | 219.1 | 211.0 |
DPO |
123.4 | 191.7 | 233.7 | 387.7 | 328.5 | 87.5 | 57.1 | 34.0 | 25.3 | 34.6 | 86.4 | 34.3 | 50.3 |
Operating Cycle |
205.3 | 351.7 | 337.8 | 352.3 | 333.5 | 183.4 | 134.1 | 168.8 | 153.0 | 172.2 | 133.0 | 245.2 | 236.2 |
Cash Conversion Cycle |
82.0 | 160.0 | 104.1 | -35.4 | 5.0 | 95.9 | 77.0 | 134.8 | 127.7 | 137.7 | 46.6 | 210.9 | 185.9 |
All numbers in USD currency
Quarterly Financial Ratios Nektar Therapeutics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | -0.31 | - | -0.49 | -790 | -0.7 | -690 | -0.68 | -0.65 | -0.61 | -0.45 | -0.78 | -0.64 | -0.56 | -0.63 | -0.69 | -0.57 | -0.56 | 5.67 | -0.6 | -0.21 | 0.39 | -0.39 | -0.42 | -0.28 | -0.32 | -0.36 | -0.14 | -0.4 | -0.06 | -0.4 | 0.26 | -0.35 | 0.55 | -0.26 | -0.37 | -0.41 | -0.14 | -0.37 | -0.48 | -0.46 | -0.38 | -0.3 | -0.36 | -0.33 | -0.21 | -0.32 | -0.33 |
EBITDA per Share |
- | -0.24 | - | -0.61 | -0.61 | -0.56 | -0.6 | -0.58 | -0.61 | -0.51 | -0.39 | -0.73 | -0.62 | -0.51 | -0.6 | -0.68 | -0.58 | -0.53 | 5.71 | -0.52 | -0.15 | 0.52 | -0.27 | -0.33 | -0.21 | -0.16 | -0.23 | -0.04 | -0.22 | 0.07 | -0.29 | 0.35 | -0.29 | 0.71 | -0.13 | -0.27 | -0.31 | 0.04 | -0.22 | -0.36 | -0.38 | -0.19 | -0.17 | -0.3 | -0.3 | -0.09 | -0.23 | -0.26 |
ROE % |
-44.06 | -65.50 | -52.49 | -66.36 | -63.85 | -53.30 | -47.19 | -40.75 | -41.26 | -38.36 | -35.29 | -35.71 | -31.36 | -29.09 | -27.68 | 36.73 | 39.67 | 6.87 | 81.78 | -42.95 | -110.09 | -119.46 | -237.82 | -224.80 | -174.21 | -968.40 | -1046.95 | -1810.85 | -1262.67 | -546.33 | -224.41 | 504.82 | -148.40 | 30.35 | -145.58 | -8.20 | 180.21 | 14.63 | -96.39 | -216.85 | -365.51 | -271.90 | -191.45 | -136.92 | -67.73 | -12.17 | -18.39 | -18.22 |
ROA % |
-25.21 | -38.25 | -32.02 | -41.17 | -40.79 | -35.37 | -32.27 | -28.31 | -28.88 | -26.94 | -24.87 | -25.25 | -22.29 | -21.18 | -20.67 | 30.09 | 31.69 | 29.61 | 46.04 | -10.91 | -19.00 | -19.77 | -39.33 | -36.11 | -26.99 | -30.43 | -24.47 | -26.49 | -16.28 | -15.77 | 1.87 | 5.04 | -12.21 | -12.83 | -32.63 | -35.07 | -37.28 | -36.95 | -41.89 | -38.94 | -34.52 | -30.07 | -25.29 | -24.40 | -22.09 | -3.97 | -6.00 | -5.94 |
ROCE % |
-51.52 | -68.14 | -49.96 | -62.14 | -53.97 | -47.63 | -43.02 | -38.06 | -39.46 | -36.98 | -34.44 | -35.13 | -31.31 | -29.35 | -28.07 | 36.52 | 40.05 | 18.53 | 103.38 | -10.98 | -67.91 | -77.02 | -193.47 | -179.28 | -128.06 | -548.33 | -504.48 | -1137.13 | -456.85 | -103.29 | 111.27 | 724.33 | -45.37 | 97.73 | -116.08 | -16.74 | 133.62 | 1.43 | -75.80 | -169.47 | -300.31 | -225.47 | -166.29 | -126.21 | -62.65 | -10.79 | -17.32 | -17.12 |
Current Ratio |
- | 2.1 | - | 2.5 | 2.5 | 2.7 | 2.9 | 3.1 | 3.3 | 3.3 | 3.3 | 3.3 | 3.5 | 3.5 | 3.5 | 3.5 | 5.0 | 5.0 | 5.0 | 5.0 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.0 | 1.0 | 1.0 | 1.0 | 1.1 | 1.1 | 1.1 | 1.1 | 0.8 | 0.8 | 0.8 | 0.8 | 1.1 | 1.1 | 1.1 | 1.1 | 1.5 | 1.5 | 1.5 | 1.5 |
DSO |
- | 22.3 | - | 96.9 | 93.9 | 105.9 | 93.5 | 131.3 | 151.2 | 118.2 | 72.7 | 68.3 | 99.2 | 114.9 | 144.0 | 129.4 | 64.5 | 92.5 | 3.6 | 57.9 | 4.8 | 3.0 | 13.2 | 38.2 | 38.2 | 39.4 | 43.7 | 27.6 | 46.2 | 30.4 | 80.3 | 9.9 | 16.8 | 2.5 | 11.5 | 13.5 | 6.5 | 3.3 | 6.0 | 15.9 | 25.1 | 28.8 | 22.4 | 27.3 | 28.6 | 16.6 | 26.0 | - |
DIO |
- | 174.9 | - | 267.7 | 230.5 | 257.3 | 187.0 | 254.4 | 322.8 | 250.5 | 241.7 | 334.7 | 193.0 | 234.6 | 230.3 | 201.7 | 139.2 | 217.1 | 188.1 | 151.8 | 100.3 | 172.5 | 108.9 | 162.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | 48.9 | - | 192.0 | 247.3 | 372.5 | 250.7 | 353.3 | 467.3 | 362.7 | 349.9 | 495.3 | 293.1 | 356.2 | 349.8 | 210.4 | 71.6 | 111.7 | 96.7 | 73.0 | 44.7 | 76.9 | 48.5 | 56.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | 197.1 | - | 364.6 | 324.4 | 363.2 | 280.4 | 385.7 | 474.0 | 368.7 | 314.4 | 403.0 | 292.1 | 349.5 | 374.4 | 331.0 | 203.7 | 309.7 | 191.7 | 209.7 | 105.1 | 175.5 | 122.1 | 200.7 | 38.2 | 39.4 | 43.7 | 27.6 | 46.2 | 30.4 | 80.3 | 9.9 | 16.8 | 2.5 | 11.5 | 13.5 | 6.5 | 3.3 | 6.0 | 15.9 | 25.1 | 28.8 | 22.4 | 27.3 | 28.6 | 16.6 | 26.0 | - |
Cash Conversion Cycle |
- | 148.2 | - | 172.6 | 77.1 | -9.3 | 29.7 | 32.4 | 6.7 | 6.0 | -35.6 | -92.3 | -0.9 | -6.7 | 24.6 | 120.6 | 132.1 | 198.0 | 95.0 | 136.6 | 60.4 | 98.6 | 73.6 | 144.1 | 38.2 | 39.4 | 43.7 | 27.6 | 46.2 | 30.4 | 80.3 | 9.9 | 16.8 | 2.5 | 11.5 | 13.5 | 6.5 | 3.3 | 6.0 | 15.9 | 25.1 | 28.8 | 22.4 | 27.3 | 28.6 | 16.6 | 26.0 | - |
All numbers in USD currency